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AbsTrACT
Introduction Identifying design features and implementation 
strategies to optimise community health worker (CHW) 
programmes is important in the context of mixed results at 
scale. We systematically reviewed evidence of the effects of 
proactive case detection by CHWs in low- income and middle- 
income countries (LMICs) on mortality, morbidity and access 
to care for common childhood illnesses.
Methods Published studies were identified via electronic 
databases from 1978 to 2017. We included randomised and 
non- randomised controlled trials, controlled before–after 
studies and interrupted time series studies, and assessed their 
quality for risk of bias. We reported measures of effect as study 
investigators reported them, and synthesised by outcomes 
of mortality, disease prevalence, hospitalisation and access 
to treatment. We calculated risk ratios (RRs) as a principal 
summary measure, with CIs adjusted for cluster design effect.
results We identified 14 studies of 11 interventions 
from nine LMICs that met inclusion criteria. They 
showed considerable diversity in intervention design and 
implementation, comparison, outcomes and study quality, 
which precluded meta- analysis. Proactive case detection 
may reduce infant mortality (RR: 0.52–0.94) and increase 
access to effective treatment (RR: 1.59–4.64) compared 
with conventional community- based healthcare delivery (low 
certainty evidence). It is uncertain whether proactive case 
detection reduces mortality among children under 5 years 
(RR: 0.04–0.80), prevalence of infectious diseases (RR: 0.06–
1.02), hospitalisation (RR: 0.38–1.26) or increases access to 
prompt treatment (RR: 1.00–2.39) because the certainty of 
this evidence is very low.
Conclusion Proactive case detection may provide promising 
benefits for child health, but evidence is insufficient to draw 
conclusions. More research is needed on proactive case 
detection with rigorous study designs that use standardised 
outcomes and measurement methods, and report more detail 
on complex intervention design and implementation.
PrOsPErO registration number CRD42017074621.
InTrOduCTIOn
Community health worker (CHW) 
programmes are experiencing a resurgence 
as a strategy to achieve health- related sustain-
able development goals. Many low- income 
and middle- income countries (LMICs) have 
implemented integrated Community Case 
Management (iCCM) of common childhood 
illnesses,1 2 a package of services delivered by 
CHWs to diagnose, treat and refer children 
under 5 with malaria, diarrhoea, pneumonia 
and malnutrition in the community setting.3 
This strategy has shown an increase in access 
to care and reduced child mortality.4–12 
However, the expected benefits have not been 
realised in all contexts.13–18 Several recent 
evaluations of national iCCM programmes in 
Key questions
What is already known?
 ► While many low- income and middle- income coun-
tries (LMICs) are adopting community health worker 
(CHW) programmes as an evidence- based strategy 
to achieve global health goals, the expected benefits 
have not been realised in all contexts.
 ► Recent reviews for developing global guidelines to 
optimise CHW programmes found a scarcity of evi-
dence on best practices for CHW education, deploy-
ment and management.
What are the new findings?
 ► Proactive case detection of common childhood ill-
nesses by CHWs in LMICs may reduce infant mor-
tality and increase access to effective treatment 
compared with conventional community- based 
healthcare delivery (low certainty evidence).
 ► Studies assessing the effects of proactive case de-
tection showed considerable diversity in terms of 
participants, interventions, comparisons, outcomes 
and study quality.
What do the new findings imply?
 ► Proactive case detection may be more effective than 
conventional community- based healthcare delivery 
in achieving child health gains.
 ► More implementation research is needed with rigor-
ous study designs and standardisation of outcomes 
to optimise the design and implementation of CHW 
programmes for impact.
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Burkina Faso, Ethiopia and Malawi did not find impacts 
on care- seeking or child mortality.19–22
These programmes shared certain design features 
that may have contributed to the lack of overall effects 
by not addressing barriers to care, such as user fees for 
services,23–25 lack of adequate CHW supervision,26–28 or 
provision only for patients who sought care from a fixed 
site. As more countries scale up CHW programmes, it 
is critical to understand how to best design and imple-
ment iCCM, and CHW services more broadly, in order to 
realise their full potential.
A recent series of systematic reviews to inform WHO 
guidelines for optimising CHW programmes found a scar-
city of evidence on best practices for several key policy areas, 
including CHW training, supervision and deployment, and 
calls specifically for more research on CHW workflow.29 
We conducted a systematic review of the evidence for 
the effectiveness of proactive case detection by CHWs to 
improve access to care and reduce morbidity and mortality. 
By proactively seeking out patients at home to offer diag-
nosis and treatment or referral, a proactive workflow has 
the potential to overcome barriers to care, including direct 
and indirect costs, distance, mistrust and gender inequality, 
reduce the time from onset of a condition to services, and 
consequently reduce disease progression and mortality.
METHOds
Inclusion criteria
Study designs
Studies from LMICs involving community- based, proactive 
case detection of common childhood illnesses were iden-
tified. Anticipating that randomised trials of healthcare 
service delivery would be very few, we included a broader 
range of study designs in line with Cochrane Effective Prac-
tice and Organisation of Care (EPOC) group recommen-
dations.30 These included randomised controlled trials 
(RCTs) and non- randomised controlled trials (NRCTs), 
controlled before–after (CBA) studies, interrupted time 
series (ITS) and repeated measure studies.
Interventions and comparisons
To be eligible for inclusion, studies needed to evaluate 
a primary healthcare intervention that included proac-
tive case- finding home visits by CHWs for the purpose of 
searching for and identifying, through history and/or 
diagnostics, cases of common childhood illness, including 
malaria, diarrhoea, pneumonia, malnutrition, HIV or 
tuberculosis. These conditions were chosen because 
they are covered by international protocols for iCCM 
of common childhood illnesses31 and/or contribute a 
substantial disease burden in LMICs. Studies needed to 
compare proactive healthcare delivery to usual or supple-
mented primary care available from facilities and/or 
CHWs that did not involve home visits for the purpose of 
identifying sick patients.
CHWs and trial participants
In accordance with earlier reviews, a CHW was defined as 
any lay health worker who received training to perform 
tasks related to primary healthcare delivery but had not 
received professional medical or paramedical educa-
tion.32 Recipients of proactive case- finding home visits 
had to include children under 5 years of age.
Outcomes
We included studies if they assessed any of the following 
outcomes: (1) mortality among children under 5 years of 
age or infants aged 0–11 months; (2) prevalence or inci-
dence of disease; (3) hospitalisation; (4) access to health-
care services; (5) harms or adverse effects; (6) costs or 
economic effects.
Our review focused on assessing proactive case detec-
tion as an adjoint to iCCM. As causes of neonatal deaths in 
LMICs differ from those of post- neonatal child deaths, we 
did not include studies that were restricted to neonates, 
that is, intervening solely in the neonatal period and 
reporting solely on neonatal outcomes. Nevertheless, we 
retained studies from our search that assessed childhood 
illness starting from the first day of life and reported 
outcomes separately for neonates and infants.
search strategy
We searched the following electronic databases for studies 
meeting the eligibility criteria, in addition to contacting 
researchers with expertise relevant to the review topic:
 ► MEDLINE Ovid (1946 to September Week 4 2017) 
(searched 10 October 2017);
 ► Embase (1947 to 2017 October 20) (searched 23 
October 2017);
 ► Global Health Database (1910 to 2017 Week 41) 
(searched 23 October 2017);
 ► Cochrane Central Register of Controlled Trials 
(searched 9 November 2017);
 ► WHO Library (searched 30 November 2017).
The search strategy included terms to capture the 
following concepts describing the intervention: (i) proac-
tive case detection—broad search terms were used to 
maximise sensitivity given a lack of MeSH terms for this 
concept; (ii) CHWs—search terms were adapted from 
a review by Lewin and colleagues32 and (iii) condition. 
A combination of two methodological search filters was 
adapted to capture a fourth concept for appropriate 
study design: (iv) the sensitivity- maximising Cochrane 
MEDLINE filter for RCTs and an EPOC filter for non- 
randomised trials. The search included publications 
since 1978, the year of the Alma- Ata Declaration, which 
marked a restructuring of the global health agenda 
towards primary healthcare provision by CHWs. No 
language restrictions were applied. Full strategies and 
results are provided in online supplementary file 1.
data collection and analysis
Selection of studies
Studies retrieved from the search were uploaded onto 
Covidence, a Cochrane technology platform for system-
atic reviews.33 Two reviewers (CW and JT or JG) inde-
pendently screened titles, abstracts and full- text articles 
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for eligibility. Inclusion was determined by consensus or 
in consultation with a third reviewer (JT or JG).
Data extraction and quality assessment
Two reviewers (CW and EW) independently extracted 
data from included studies related to study identification, 
methods, population, interventions, implementation of 
intervention, outcomes and results using a data extrac-
tion form designed in Covidence. Two reviewers (CW 
and EW) independently assessed the quality of included 
studies using the EPOC risk of bias tool for studies with 
a separate control group;34 allocation concealment was 
removed from the quality assessment criteria as reviewers 
deemed this domain inapplicable due to the nature of 
the intervention under review. Consensus on data extrac-
tion and quality assessment was reached in discussion or 
in consultation with a third reviewer (JT or JG).
Data synthesis
We reported measures of effect in the same way that 
study investigators reported them and synthesised them 
by type of outcome. For studies with a separate control 
group, we included only the measure of effect derived by 
comparing the intervention group to the control group, 
if multiple comparisons were reported. For studies with 
no separate control group, we included baseline to 
end- line comparisons. We calculated risk ratios (RRs) 
for dichotomous data to allow for comparisons across 
studies. If appropriate denominators (eg, number of 
live births for mortality outcomes) were not reported, 
we used population estimates reported in the study to 
approximate the denominator. We calculated 95% CIs, 
adjusting for clustering using the intracluster correlation 
coefficient (ICC) reported in the study, if available.35 If 
not available, we used a conservative ICC of 0.05 for all 
studies with a cluster design, as the ICC was <0.001 in 
the three studies for which it was reported. We assessed 
heterogeneity across studies for each outcome type both 
qualitatively and quantitatively using the I2 statistic, which 
describes the percentage of total variation across studies 
that is due to heterogeneity rather than chance.36 Two 
reviewers (CW and JT or JG) independently assessed the 
certainty of evidence for each analysis using the Grading 
of Recommendations, Assessment, Development and 
Evaluation approach,37 38 which takes into account study 
design, risk of bias, inconsistency, indirectness/applica-
bility, imprecision and strength of association. Consensus 
was reached through discussion or in consultation with a 
third reviewer (JT or JG).
rEsulTs
Characteristics of included studies
Excluding duplicates, a total of 442 abstracts were 
screened for eligibility (figure 1 in online supplemen-
tary file 2). Fourteen studies were included, including 
five cluster RCTs (table 1). Complete information on the 
characteristics and risk of bias for each study is available 
in online supplementary file 3.
Study settings
Among the 14 included studies, seven were from Africa 
(three KwaZulu- Natal, South Africa,39–41 two Mali,42 43 
one Ethiopia44 and one Senegal.45 The two reports from 
Mali42 43 and the two from rural South Africa,40 41 respec-
tively, studied the same interventions delivered to the 
same populations, differing only with regard to when—
and in South Africa, how—impact was assessed. Six 
studies were from Southeast Asia (three India,46–48 one 
Bangladesh,49 one Nepal50 and one Pakistan.51 Two 
reports from Haryana, India47 48 evaluated the same inter-
vention delivered to the same population but assessed 
different outcomes. One study was from the Americas, 
in Dominican Republic.52 Four studies took place in 
urban or periurban settings,39 42 43 52 and eight in rural 
settings;40 41 44–46 49–51 the studies in Haryana47 48 did not 
indicate whether the setting was rural or urban.
Study designs and outcomes
The KwaZulu- Natal, South Africa39–41 and Haryana, 
India47 48 studies were cluster RCTs that evaluated a range 
of access to care, morbidity and mortality outcomes; 
the rural South Africa study did not report outcomes 
separately for children under 5 years.40 41 Two studies 
were NRCTs that measured morbidity outcomes;49 52 
the Bangladesh study did not report outcomes sepa-
rately for children under 5 years.49 The Nepal study50 
that used a non- randomised, stepped- wedge design to 
assess risk of death among infants and children did 
not compare results between early and late treatment 
groups. Instead, it compared annual risks to baseline 
and used a test for trend to assess programme maturity. 
This study was therefore considered in this review to 
be an uncontrolled before–after study from baseline to 
end- line.
Four studies used a CBA design44–46 51 and reported 
percent differences or difference- in- differences for 
mortality, morbidity or access to care outcomes. However, 
some did not use the baseline or control group appro-
priately. The Pakistan study51 reported different baseline 
years for intervention and control areas; therefore, this 
study was deemed a NRCT and only the postintervention 
comparison between groups was presented in this review. 
The Ethiopia study44 presented a number of before–after 
access to care indicators for the intervention group, but 
only present before–after data for the comparison group 
for one outcome, the tuberculosis case notification rate; 
outcomes were not reported separately for children 
under 5 years. Finally, the Mali studies42 43 were included 
as ITS designs; yet, with only one baseline, they lacked a 
comparative preintervention trend and thus were treated 
in the review as uncontrolled before–after studies from 
baseline to end- line.
Participants
Half of the studies extended CHW services to the entire 
population,42–45 49 53 54 among which only the Mali 
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studies42 43 reported outcomes specifically for children 
under 5 years. Five studies recruited pregnant women 
and delivered a mother–child intervention during the 
neonatal period, and in some cases, into infancy and 
childhood.39 46–48 52 The remaining two studies tested 
interventions that targeted children under 5 years of age 
during a period of 3 years.50 51
Characteristics of CHW programmes
The Bangladesh,49 Ethiopia,44 Senegal,45 rural South 
Africa40 41 and more recent India47 48 studies provided 
supplemental training in the context of the study (two- 
half days in Bangladesh, 1 day in Senegal, 8 days in India, 
60 days in South Africa and unreported in Ethiopia) 
to CHWs from an already established CHW cadre. The 
remaining studies evaluated CHW programmes initiated 
by a research institute, all of which recruited local, literate 
community members and trained them for a duration of 
60 hours52 to 6 months.46 In half of all programmes, CHWs 
were exclusively or predominantly female. Reporting of 
recipient and CHW sample sizes, and therefore CHW to 
population ratios, was poor.
Eleven studies reported enhanced CHW supervision as 
an adjunct to the intervention. However, the supervision 
strategy and frequency were not adequately described. 
Supervisors included physicians,46 nurses,51 accredited 
social health activists47 48 or senior project staff42 50 who 
monitored CHW activities periodically. Other studies 
employed a dedicated cadre of CHW supervisors, either 
based at the facility40 41 or in the community.43 44 Eleven 
studies paid CHWs for their work, with a salary in- line 
with government standards,39 43 44 50 a performance- 
linked46 or task- based47 48 remuneration scheme, or some 
other form of payment.40 41 45
CHWs provided services for the range of conditions 
eligible for inclusion in the review. CHWs in Mali,42 43 
India46–48 and periurban South Africa39 provided inte-
grated management of common neonatal and childhood 
illnesses. CHWs provided care exclusively for diarrhoea in 
Bangladesh;49 for pneumonia in Pakistan and Nepal;50 51 
for malaria in Senegal;45 for malnutrition and at risk of 
being overweight in Dominican Republic;52 for tubercu-
losis in Ethiopia;44 and for HIV, tuberculosis, and sexually 
transmitted infections in rural South Africa.40 41 In addi-
tion to proactive case detection, most studies included 
doorstep treatment by CHWs and referral to a facility if 
necessary, with the exception of the studies in Dominican 
Republic, Ethiopia and periurban South Africa,39 44 52 
which limited postdetection activities to referral for treat-
ment and home- based follow- up.
Most studies compared proactive case detection by 
CHWs to the standard of care—passive case detection at 
public or private health facilities; six studies also included 
passive case detection by CHWs in the control arm. 
The South African studies included control CHWs who 
conducted home visits for purposes other than proactive 
case detection. Control arm CHWs conducted one preg-
nancy and two postnatal home visits to assist with securing 
identity documents and social grants in the urban study,39 
and home visits to promote and refer clients to HIV coun-
selling and testing in the rural studies.40 41
risk of bias of included studies
Risk of bias summaries are provided in online supplemen-
tary file 2 (figure 2 and figure 3). Risk of bias assessments 
for each study are provided in online supplementary file 
3. These assessments were considered when interpreting 
the results and certainty of evidence for each outcome.
Selection bias
All studies, with the exception of those in Mali,42 43 
allocated the study area into intervention and control 
groups. Five studies used cluster randomisation to assign 
groups.39–41 47 48 Among seven studies that did not use 
random allocation, sufficient evidence was provided in 
only two45 46 that outcome measurements were similar 
between groups at baseline, and in only three46 50 52 that 
population- level and/or cluster- level characteristics were 
similar between groups at baseline.
Performance bias and detection bias
Due to the nature of the intervention, blinding of partic-
ipants and study personnel to allocation assignment was 
not possible and was scored high risk for all included 
studies. All six Southeast Asian studies46–51 and the 
periurban South Africa study39 blinded outcome asses-
sors to allocation assignment, earning a low detection 
bias score.
Attrition bias
Reporting of incomplete outcome data varied consider-
ably between studies. Studies involving pregnant women 
for a neonatal intervention discussed attrition bias with 
the use of a trial profile.39 47 48 52 A Data Safety and Moni-
toring Board stopped the Haryana, India trials early after 
the required sample size had been met, but prior to about 
half of children completing the 12- month assessment.47 48 
Risk of attrition bias was high in the Dominican Republic 
study where roughly a quarter of mother–child dyads 
were lost, and there were statistically significant differ-
ences in some baseline characteristics that could be asso-
ciated with the outcome between those who completed 
follow- up and those who did not.52 Missing survey data 
for date of birth and death were imputed in the Mali 
studies, but the extent and patterns of missing data were 
explicitly reported.42 43 Studies from India46 and Nepal50 
did not comment on completeness of outcome data, but 
data were collected by an independent set of workers 
and analysed on an intention to treat basis. CBA studies 
in Pakistan51 and Senegal45 relied on CHWs to collect 
outcome data in intervention clusters and employed 
periodic surveys in control clusters. These studies did not 
discuss incomplete outcome data and were scored high 
risk due to the differences in data source and methods 
between the two groups.
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Reporting bias
A published protocol was found for only one study.39 No 
studies reported outcomes in the methods that were then 
subsequently omitted from the results and, therefore, no 
studies were scored as being at high risk of reporting bias. 
Some studies subsequently added outcomes from posthoc 
analyses, but provided justifiable reasons for inclusion of 
the additional outcomes that were not prespecified.39 47 48
Protection against contamination
Risk of bias due to contamination was scored as low when 
large units of allocation were chosen and efforts to mini-
mise contamination were discussed and/or a map was 
provided showing geographic separation of groups.44 46–50
Effects of interventions
Eleven studies assessed the effects of proactive case 
detection of common childhood conditions by CHWs 
on mortality, morbidity or access to curative services and 
were included in the main analysis. Meta- analysis was 
deemed inappropriate as the studies in each analysis 
represented considerable clinical diversity with respect 
to intervention and participant characteristics, method-
ological diversity with respect to study design and risk of 
bias, and statistical heterogeneity as quantified by the I2 
statistic. We were unable to explore this heterogeneity 
by prespecified subgroup analyses due to the limited 
number of studies. Overall, the certainty of evidence is 
low or very low because of limitations in study design, 
indirect measures of effect due to cointerventions or 
comparisons and unexplained heterogeneity.
Mortality
Seven studies measured mortality outcomes (table 2; 
Figure 1). Proactive case detection may reduce neonatal 
mortality (low certainty evidence). However, the effects 
vary and it is possible that it makes little or no differ-
ence to neonatal mortality (calculated RRs: 0.43 to 1.07; 
I2=79.1%). Proactive case detection may reduce infant 
mortality (calculated RRs: 0.52 to 0.94; I2=61.9%) (low 
certainty evidence). It is uncertain whether proactive 
case detection reduces mortality among children under 
5 years (calculated RRs: 0.04 to 0.80; I2=94.4%) because 
the certainty of this evidence is very low.
Three studies assessed impact on neonatal mortality 
over a 2–3 year timeframe (table 2; Figure 1). It was the 
primary outcome in the Maharashtra46 and Haryana47 
studies of proactive case detection of newborn and infant 
danger signs, infections and illnesses. In rural Maha-
rashtra, there was a 62% reduction in intervention areas 
compared with control areas (p<0.001).46 In Haryana, the 
neonatal mortality rate beyond the first 24 hours of life 
was lower in intervention clusters than in control clusters 
(adjusted HR=0.86; 95% CIs: 0.79 to 0.95), but not the 
case for the neonatal mortality rate overall—an effect, 
they explained, due to the higher than expected propor-
tion of neonatal deaths occurring in the first 24 hours 
on which the intervention was unlikely to have had an 
effect.47 In both Maharashtra and Haryana, interven-
tion groups included a mother’s education component 
and system strengthening in terms of user fee removal 
for CHW care46 or training of other provider cadres in 
Integrated Management of Newborn and Childhood 
Illnesses.47 An exploratory analysis of the effect of a home 
visit programme in periurban South Africa to improve 
appropriate infant feeding and HIV- free infant survival39 
on neonatal mortality showed an increased risk of death 
in intervention compared with control clusters, although 
the effect was not statistically significant (RR=1.07; 95% 
CIs: 0.69 to 1.63).
Four Southeast Asia studies assessed infant mortality. 
The Maharashtra46 and Haryana47 studies found signif-
icant reductions (respectively, 45.7%; p<0.001 and 
AHR=0.89; 95% CIs: 0.78 to 1.00) in infant mortality 
between intervention and controls. Proactive case detec-
tion of childhood respiratory infection and doorstep 
treatment of suspected pneumonia compared with facility- 
based care led to reductions in infant mortality in rural 
Nepal,50 where cotrimoxazole was provided at home free 
of charge, and in rural Pakistan,51 where CHWs treated at 
home or referred to facilities where treatment protocols 
had been standardised. In Nepal, the greatest reduction 
in mortality after 3 years of intervention activities was 
seen in infants aged 6–11 months (RR=0.36; 95% CIs: 
0.24 to 0.56). In Pakistan,51 the infant mortality rate was 
74/1000 in the intervention area during the first 2 years 
of the study compared with 93/1000 in the control area.
A reduction in mortality was seen for all children under 
5 years of age in Nepal, with a relative risk reduction of 
0.72 from baseline to year 3,50 and in Pakistan, with a 26% 
reduction between intervention (29/1000) and control 
(39/1000) areas during the first 2 years of the study.51 In 
periurban Mali, the under-5 mortality rate declined from 
154/1000 at baseline to 25/1000 after 3 years of proac-
tive case detection of common childhood conditions in 
addition to primary health centre reinforcements and 
removal of user fees, and to 7/1000 after 7 years.43
Morbidity
Six studies assessed prevalence of disease, and four 
assessed hospitalisation (table 3; Figure 2). Proactive 
case detection may improve nutritional outcomes (low 
certainty evidence), although the effects vary, and it 
is possible that it makes little or no difference to nutri-
tional outcomes (calculated RRs range from 0.61 to 
1.16; I2=61.4%). It is uncertain whether proactive case 
detection reduces the prevalence of infectious diseases 
(calculated RRs: 0.06 to 1.02; I2=90.6%) or hospitalisa-
tion (calculated RRs: 0.38 to 1.26; I2=94.5%) because the 
certainty of this evidence is very low.
In Mali42 43 and rural Senegal,45 proactive case detec-
tion of malaria led to significant reductions in the odds 
of febrile illness among children under five (adjusted 
OR (AOR) after 7 years=0.45; 95% CIs: 0.32 to 0.62), 
and symptomatic malaria among the general popula-
tion in intervention villages compared with control 
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Table 2 Intervention effects on mortality outcomes
Country Design*
Reported measure of effect (95% 
CIs)† Calculation of risk‡ Calculated RR§
Neonatal mortality
India46¶ CBA % diff=62.2%; p<0.001 I: 25/979
C: 66/1108
0.43 (0.27, 0.67)
India47¶ cRCT AHR=0.91 (0.80 to 1.03) I: 1244/29667
C: 1326/30813
0.97 (0.71, 1.33)
SA39 cRCT RR=1.07 (0.69 to 1.63) I: 20/1821
C: 22/2136
1.07 (0.58, 1.95)
Infant mortality
India46 CBA % diff=45.7%; p<0.001 I: 38/979
C: 83/1108
0.52 (0.36, 0.75)
India47¶ cRCT AHR=0.89 (0.78 to 1.00) I: 1925/29667
C: 2136/30813
0.94 (0.73, 1.20)
Nepal50 BA 0 to 6 days: RR=0.80 (0.59, 1.10)
0.25 to 5 months: RR=0.74 (0.58, 0.94)
6 to 11 months: RR=0.36 (0.24, 0.56)
I: 236/13406
C: 199/6684
0.60 (0.37, 0.96)
Pakistan51¶ cNRCT % diff=21%; ‘not significant’ I: 108/4665
C: 31/1194
0.87 (0.52, 1.46)
Child mortality
Mali42 BA HR=0.10; p<0.0001 I: 29/1390
C: 38/316
0.17 (0.11, 0.28)
Mali43 BA HR=0.039 (0.013 to 0.116) I: 5/1023
C: 39/330
0.04 (0.02, 0.10)
Nepal50¶ BA RR=0.72 (0.63 to 0.82) I: 409/13406
C: 301/6684
0.67 (0.46, 0.98)
Pakistan51¶ cNRCT % diff=26%; p<0.001 I: 149/4665
C: 47/1194
0.80 (0.52, 1.22)
Neonatal period reported is 0–27 days. Infant period is 0–11 months. Child mortality period is 0–59 months. India46 also reports mortality 
separately for early (0–6 days) neonates: % diff=57.3%; p<0.001; calculated RR=0.45, and late (7–27 days) neonates: % diff=51.6%; 
calculated RR=0.31. Study also found a reduction in perinatal mortality % diff=71.0%; p<0.001. A 2005 summary of this field trial reports 
that reductions in neonatal mortality and infant mortality reached 70% (95% CIs: 59, 81%) and 57% (95% CIs: 46, 68%), respectively, 
after 8 years postintervention.65 India47 also reports mortality for neonates after the first day of life: AHR=0.86 (0.79 to 0.95); calculated 
RR=0.93. Study also found a reduction in perinatal (AHR=0.89; 95% CIs: 0.78 to 1.00) and postneonatal (AHR=0.76; 95% CIs: 0.67 to 0.85) 
mortality. Nepal50 reports no overall infant mortality, only by infant age brackets; denominators for calculated infant and childhood risks are 
based on study report that initial census registered66 84 children (control) and an additional 6722 were born during the study for a total of 
13 406 children available (intervention). Pakistan51 compares mortality rates between intervention and control periods for the 1985–1986 
postintervention period; calculated risks are for 1985 only for which the study reports number of children per arm. Nepal50 and Pakistan51 
also report disease- specific mortality rates; results not shown. The South Africa39 study found no effect (RR=0.97; 95% CIs: 0.67 to 1.40) on 
the primary joint mortality–morbidity outcome: HIV- free infant survival at 12 weeks among HIV- positive mothers.
*The study design reported is the nature of the comparative data, not necessarily the design as described by study authors.
†The before–after (BA) studies42 43 50 reported each annual time point compared with baseline; here we present end- line to baseline risk 
ratios.
‡Reviewer (CW) calculated risk of death for intervention (I) and comparison (C) groups by taking number of events over number of live births 
(or, if unavailable, over population). For CBA, cRCT and cNRCT study designs, risks were calculated and compared (ie, calculated risk ratio) 
for the postintervention period between intervention and control groups; for BA study designs, intervention risk was calculated at end- line 
and control risk at baseline.
§Risk ratios and 95% CIs are adjusted for clustering.
¶Study primary outcome(s).
AHR, adjusted HR; BA, before–after; CBA, controlled before–after; cNRCT, cluster non- randomised controlled trial; cRCT, cluster randomised 
controlled trial; RR, risk ratio.
villages (AOR=0.03; 95% CIs: 0.02 to 0.07), respec-
tively. The Haryana48 study found significant reduc-
tions in danger signs (adjusted RR (ARR)=0.82; 95% 
CIs: 0.67 to 0.99) and local infection (ARR=0.91; 95% 
CIs: 0.71 to 1.17) among neonates, as well as diarrhoea 
(ARR=0.63; 95% CIs: 0.49 to 0.80) and pneumonia 
(ARR=0.60; 95% CIs: 0.46 to 0.78) among infants. The 
urban South Africa39 and Dominican Republic52 studies 
found no effects on childhood diarrhoea, a secondary 
intervention outcome.
The Dominican Republic52 study found that monthly 
home visits and mother’s groups to promote healthy 
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Figure 1 Forest plots for neonatal (top), infant (middle) and under 5 (bottom) mortality. CBA, controlled before–after; RR, risk 
ratio.
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Table 3 Intervention effects on morbidity and access to care outcomes
Country Design* Population/condition†
Reported measure of effect (95% 
CIs)‡ Calculated RR (95% CIs)§
Prevalence of infectious diseases¶
DR52 cNRCT Diarrhoea, children under two AOR=0.99 (0.59 to 1.67) 0.95 (0.61 to 1.47)
India48 cRCT Infant** diarrhoea ARR=0.63 (0.49 to 0.80) 0.63 (0.54 to 0.74)
India48 cRCT Infant** pneumonia ARR=0.60 (0.46 to 0.78) 0.56 (0.40 to 0.77)
Mali42 BA Childhood febrile illness PR=0.61; p<0.001 0.61 (0.51 to 0.73)
Mali43 BA Childhood febrile illness AOR=0.45 (0.32 to 0.62) 0.57 (0.47 to 0.68)
Senegal45†† CBA Malaria, all ages AOR=0.03 (0.02 to 0.07) 0.06 (0.02 to 0.18)
SA39 cRCT Infant diarrhoea at 12 weeks RR=1.01 (0.90 to 1.14) 1.02 (0.90 to 1.16)
Prevalence of nutritional outcomes‡‡
DR52†† cNRCT Stunting, children under 2 AOR=0.50 (0.22 to 1.10) 0.61 (0.33 to 1.11)
DR52†† cNRCT Overweight, children under 2 AOR=0.43 (0.23 to 0.77) 0.69 (0.47 to 1.03)
DR52†† cNRCT LAZ scores, children under 2 MD=0.21 (-0.02 to 0.44) NA
DR52†† cNRCT BAZ scores, children under 2 MD=−0.31 (-0.49 to -0.12) NA
India48 cRCT Infant stunting ARR=0.99 (0.94 to 1.04) 1.03 (0.93 to 1.14)
India48 cRCT Infant wasting ARR=1.10 (0.90 to 1.36) 1.16 (0.93 to 1.46)
SA39 cRCT Infant LAZ scores at 12 weeks MD=0.11 (0.03 to 0.19) NA
SA39 cRCT Infant WLZ scores at 12 weeks MD=0.01 (-0.07 to 0.09) NA
SA39 cRCT Infant WAZ scores at 12 weeks MD=0.09 (0.00 to 0.18) NA
Hospitalisation§§
Bangladesh49†† cNRCT For diarrhoea, all ages % diff=29%; p<0.01 0.38 (0.34 to 0.41)
DR52 cNRCT During first 2 years of life AOR=1.09 (0.70 to 1.68) 1.07 (0.77 to 1.49)
India48 cRCT During infancy** ARR=0.67 (0.51 to 0.88) 0.65 (0.46 to 0.91)
SA39 cRCT For infant diarrhoea at 12 weeks RR=1.28 (0.75 to 2.19) 1.26 (0.67 to 2.39)
Access to effective¶¶ treatment
DR52 cNRCT Diarrhoea, children under two AOR=3.86 (1.14 to 13.02) 1.29 (0.79 to 2.12)
India48†† cRCT Infant** diarrhoea ARR=1.22 (1.06 to 1.42) 1.25 (1.11 to 1.41)
India48†† cRCT Infant** pneumonia ARR=1.44 (1.00 to 2.08) 1.24 (0.71 to 2.14)
Access to prompt*** treatment
India48†† cRCT Infant** diarrhoea ARR=0.99 (0.89 to 1.10) 1.00 (0.88 to 1.14)
India48†† cRCT Infant** pneumonia ARR=1.10 (0.96 to 1.25) 1.01 (0.84 to 1.22)
Mali42†† BA Childhood malaria PR=1.89; p=0.0195 1.89 (1.18 to 3.05)
Mali43†† BA Childhood malaria AOR=3.20 (1.75 to 5.85) 2.39 (1.49 to 3.83)
*The study design reported is the nature of the comparative data in this review.
†Neonatal period is 0–27 days, infant period is 0–11 months and childhood is under 5 years of age, unless otherwise indicated.
‡The BA studies42 43 50 reported each annual time point compared with baseline; here we present effect estimates comparing end- line to baseline.
§For CBA, cRCT and cNRCT study designs, risks were calculated and compared for the postintervention period between intervention and control groups; 
for BA designs, intervention risk was calculated at end- line and control risk at baseline. Risk ratios and 95% CIs are adjusted for clustering.
¶For the Dominican Republic,52 India,48 Mali42 43 and South Africa39 studies, prevalence based on mother’s reporting of condition during 2 weeks period 
preceding the interview; for the Senegal45 study, prevalence measured at each time point by positive rapid diagnostic test of symptomatic community 
members.
**The India48 study also reported effects of similar magnitude at 6 months of age; results not shown. Study found a reduction in neonatal morbidity: danger 
signs (ARR=0.82; 95% CIs: 0.67 to 0.99) and infection (ARR=0.91; 95% CIs: 0.71 to 1.17), and an increase in access to care for neonates: treatment by 
appropriate provider for danger signs (ARR=1.76; 95% CIs: 1.36 to 2.24), prompt treatment for danger signs (ARR=1.14; 95% CIs: 1.10 to 1.18), treatment 
by appropriate provider for infections (ARR=4.86; 95% CIs: 3.80 to 6.21) and prompt treatment for infections (ARR=1.97; 95% CIs: 1.71 to 2.27).
††Study primary outcome(s).
‡‡Based on anthropometric measures for all studies.
§§Measure based on mother’s recall for Dominican Republic52 (last 12 months), India48 (last 3 months) and South Africa39 (recall period not specified) 
studies; for the Bangladesh49 study, measure based on hospital records. CHWs in the Dominican Republic52 and South Africa39 studies did not provide 
doorstep treatment but referred all cases detected; CHWs in the Bangladesh49 and India48 studies provided doorstep treatment and referral.
¶¶Defined for the Dominican Republic52 study as oral rehydration for childhood diarrhoea, and for the India48 study as treatment from an appropriate 
provider, which included physicians in government and private facilities, auxiliary nurse midwife, Anganwadi worker (CHW) or ASHA.48
***Defined as treatment within 24 hours of symptom onset for all studies.
AOR, adjusted OR; ARR, adjusted risk ratio; ASHA, accredited social health activists; BA, before–after; BAZ, Body Mass Index- for- age; CBA, controlled 
before–after; CHW, community health worker; cNRCT, cluster non- randomised controlled trial; cRCT, cluster randomised controlled trial; LAZ, length- for- 
age; MD, mean difference; NA, not applicable; RR, risk ratio; WAZ, weight- for- age; WLZ, weight- for- length.
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Figure 2 Forest plots for prevalence of common childhood infections (top) and nutritional conditions (middle), and 
hospitalisation (bottom). BA, before–after; CBA, controlled before–after; RR, risk ratio.
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Figure 3 Forest plots for access to effective treatment (top) and prompt access to treatment (bottom). RR, risk ratio.
babies and monitor physical growth during the first 
2 years of life led to reductions in stunting (AOR=0.50; 
95% CIs: 0.22 to 1.10) and risk of overweight (AOR=0.43; 
95% CIs: 0.23 to 0.77), compared with standard facility- 
based controls. The Haryana48 study found no effect on 
wasting (ARR=0.99; 95% CIs: 0.94 to 1.04) or stunting 
(ARR=1.10; 95% CIs: 0.90 to 1.36) at 12 months of age 
in exploratory analyses. The South Africa39 study found 
an increase in infant weight- for- age (mean difference 
(MD)=0.09; SD: 0.00, 0.18) and length- for- age (MD=0.11; 
SD: 0.03, 0.19) z- scores, but not weight- for- length 
(MD=0.01; SD: -0.07, 0.09).
In Bangladesh,49 CHW home visits to inquire about 
diarrhoea and offer oral rehydration therapy packets 
free of charge were associated with a 29% reduction 
(p<0.01) in hospitalisation for diarrhoea compared 
with control villages with CHWs doing ‘surveillance and 
health work’. In the Haryana48 study, in which CHWs 
assessed newborns for signs of illness at each visit and 
treated or referred them, caregivers in the interven-
tion clusters reported fewer hospital admissions during 
infancy (ARR=0.67; 95% CIs: 0.51 to 0.88). In the South 
Africa39 and Dominican Republic52 studies, where 
proactive CHWs did not offer doorstep treatment but 
referred all cases detected, caregivers reported more 
hospital admissions for their children, although results 
were not statistically significant.
Access to treatment
Four studies assessed access to effective and/or prompt 
treatment (table 3; Figure 3). Proactive case detection 
may increase access to effective treatment (calculated 
RRs range from 1.59 to 4.64; I2=97.0%) (low certainty 
evidence). It is uncertain whether proactive case detec-
tion increases access to prompt treatment (calculated RRs 
range from 1.00 to 2.39; I2=84.9%) because the certainty 
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of this evidence is very low. Three studies assessed the 
effects of proactive case detection of HIV and/or tuber-
culosis on access to diagnostic services and/or treatment 
adherence support; these were excluded from the main 
analysis and summarised in online supplementary file 4.
In Dominican Republic,52 proactive home visits 
increased the proportion of diarrhoeal children who 
received oral rehydration solution (AOR=3.86; 95% CIs: 
1.14 to 13.02). In Haryana,48 caregivers in intervention 
clusters were more likely to seek any treatment within 
24 hours and treatment from an appropriate provider for 
newborns with danger signs (respectively, ARR=1.14; 95% 
CIs: 1.10 to 1.18 and ARR=1.76; 95% CIs: 1.36 to 2.24) 
and local infections (respectively, ARR=1.97; 95% CIs: 
1.71 to 2.27 and ARR=4.86; 95% CIs: 3.80 to 6.21). Care-
givers were no more likely to seek any treatment within 
24 hours for infants with diarrhoea (ARR=0.99; 95% CIs: 
0.89 to 1.10) or pneumonia (ARR=1.10; 95% CIs: 0.96 to 
1.25), but more likely to seek treatment from an appro-
priate provider for diarrhoea (ARR=1.22; 95% CIs: 1.06 
to 1.42) or pneumonia (ARR=1.44; 95% CIs: 1.00 to 
2.08). In Mali,42 43 a higher proportion of children with 
fever received antimalarial treatment within 24 hours of 
symptom onset compared with baseline (AOR=3.20; 95% 
CIs: 1.75 to 5.85).
dIsCussIOn
summary and quality of evidence
This review identified 14 studies of 11 different inter-
ventions involving proactive case detection of common 
childhood conditions by CHWs in nine LMICs. Findings 
are summarized in table 4. Proactive case detection may 
reduce infant mortality and increase access to effective 
treatment compared with conventional community- 
based healthcare delivery (low certainty evidence). 
Although our review suggests that proactive case detec-
tion may also reduce mortality among children under 
5 years, prevalence of infectious diseases, hospitalisation 
and improve access to prompt treatment, it is uncertain 
because the certainty of this evidence is very low. Proac-
tive case detection may reduce neonatal mortality and 
improve nutritional outcomes (low certainty evidence), 
although effects vary and it is possible that it makes little 
or no difference to these outcomes.
Three high- quality studies from India46–48 provide 
evidence that proactive case detection of illnesses among 
newborns and infants reduced neonatal and infant 
mortality, morbidity, and improve treatment seeking, 
compared with a conventional community- based 
approach. Two moderate quality studies in Senegal45 and 
Bangladesh49 found that proactive case detection and 
doorstep treatment significantly reduced population- 
level morbidity, as measured by the prevalence of malarial 
fever and hospitalisation for diarrhoea, respectively. In 
these five studies, control groups received passive case 
detection and management from community- based 
CHWs and primary health facilities. This provides a more 
direct assessment of the effectiveness of proactive case 
detection than studies that had no CHWs in control clus-
ters (which are likely to overestimate its effects) as well 
as studies with control CHWs who conduct home visits 
for other purposes (which are likely to underestimate 
its effects). Activities in control clusters may partially 
explain the null effects on neonatal mortality and infant 
morbidity found in the periurban South Africa cluster 
RCT.39 Home visits by control CHWs for the purpose of 
procuring identity documents and social grants may have 
served in practice to proactively identify sick children 
and encourage caregivers to seek care.
Our review extracted all study outcomes that met our 
inclusion criteria, even if those outcomes were the result 
of exploratory or posthoc analyses. This may account 
for some of the null effects in studies that reported 
numerous outcomes for which the study was not powered 
or for which the intervention had no clear pathway for 
impact. For example, finding no effect on prevalence of 
diarrhoea for visits targeting nutrition,52 and no effect 
on stunting for visits to detect disease in infants were the 
results of exploratory analyses and small sample sizes.47
Although this review found large inconsistencies in 
results for hospitalisation, the two studies in which CHWs 
provided doorstep treatment found a significant reduc-
tion,47 49 whereas the two urban studies39 52 in which all 
cases were referred found an increase (although statisti-
cally not significant), as might be expected. These were 
the only studies included in the main analyses in which 
CHWs did not offer doorstep treatment following proac-
tive detection of uncomplicated cases. In the studies 
concerning HIV and/or tuberculosis, CHWs referred 
cases detected and then conducted follow- up home visits 
for treatment adherence support.
Most studies evaluated complex interventions with 
multiple components, limiting our ability to draw conclu-
sions about the isolated effects of proactive case detec-
tion. At a minimum, all studies likely included—whether 
or not explicit in the intervention description—health 
promotion and education messaging by CHWs at the 
time of home visitation, the benefits of which on child 
health have been documented.55–57 Other cointerven-
tions included additional support to proactive CHWs in 
the form of supervision and/or remuneration; systems 
strengthening such as facility- level improvements and/
or user fee removal; community mobilisation and/or 
women’s groups. Studies that found the intervention 
effective, such as those in India, Senegal, Bangladesh and 
Mali, offered more in terms of supportive cointerven-
tions, suggesting these are important design features of 
successful CHW programmes.
Overall, the quality of studies evaluating proactive 
case detection was poor. Our review identified only 
three cluster RCTs that evaluated mortality, morbidity 
or access to treatment; two of which were the same trial 
reporting different outcomes.47 48 Our results show clear 
design effect, with studies at higher risk of bias showing 
a larger magnitude of effect than the RCTs (tables 2 and 
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3; Figures 1 and 2). Risk of bias was higher still where 
inappropriate analytical methods were employed for the 
study design.50 51 Additionally, studies published before 
the year 2000 did not account for clustering in their 
analytical approaches.46 49–51
limitations
Our synthesis of evidence was limited by the small number 
of eligible studies, and the considerable diversity between 
them. With only 11 studies included in the main analyses, 
we were unable to conduct subgroup analyses that would 
have tested for differences in effectiveness by features in 
study and intervention design, including setting, CHW 
characteristics, target populations, diseases detected 
or frequency of home visits. We could not explore how 
different health conditions in different transmission 
settings or health system contexts would have differen-
tial impacts on outcomes. We were also unable to assess 
publication bias due to the limited number of studies. 
However, our review included large trials reporting statis-
tically non- significant results, so there are no specific 
reasons for suspecting a high risk of publication bias.
Our synthesis was further limited by inadequate 
reporting of methods and results in some studies. We 
had to make some assumptions in order to calculate a 
principal summary measure for between study compar-
isons, such as approximating the denominator or postu-
lating the ICC. Features of CHW intervention design 
and implementation, including CHW recruitment and 
training, support and supervision and health system 
integration, were inadequately described. Comparisons 
were also inadequately described, making it difficult to 
understand the differences between the two groups. In 
some cases, it was not clear whether the control included 
CHWs at all,44 what services were offered by control 
CHWs, including whether they conducted home visits for 
other purposes,40 41 49 or whether they received the addi-
tional support, such as supervision or payment, offered 
to intervention CHWs.45
As there is no universally adopted terminology or 
strong indexation in health databases for the concept 
of proactive case detection, it is possible that some 
published or unpublished evaluations meeting the inclu-
sion criteria were not identified through the search. 
There is a large body of evidence for the mortality, 
morbidity and access to care impacts of comprehensive 
community- based primary healthcare interventions,58 59 
including household and community integrated manage-
ment of childhood illness60–62 that may include home 
visits by community- based providers for the purpose of 
health promotion and education, vital registration and/
or proactive case detection. Some of these studies56 57 63 
may not have been included because insufficient infor-
mation was available about the role of home visits in 
disease detection, study designs did not permit compar-
isons based on workflow and/or study designs were not 
sufficiently rigorous.
Implications for research and practice
The review process to inform the WHO guidelines for 
optimising CHW programmes found a scarcity of evidence 
for several areas reviewed, including recruitment and 
training, supervision and management, and health system 
integration.29 64 Our review synthesising evidence around 
CHW workflow yielded similar conclusions regarding 
inadequate reporting of programme characteristics and 
lack of robust evidence. These features merit further 
consideration by programme architects and evaluators.
Standardising impact metrics for evaluating CHW 
programmes would greatly facilitate the synthesis of 
evidence in this field. Possible impact metrics include 
mortality among vulnerable groups, morbidity, as 
measured by disease prevalence, and access to prompt, 
effective treatment. Researchers should also consider 
process outcomes that provide an understanding of 
why and how a complex intervention did or did not 
work. None of the studies identified through the search 
provided a comparative costing analysis, or reported 
adverse effects of the intervention to patients, providers 
or the health system. These are important data points for 
practitioners and policymakers designing, implementing 
and scaling- up CHW interventions.
Finally, given that neonatal mortality is becoming an 
increasingly large proportion of mortality among chil-
dren under 5 years of age, currently accounting for 45% 
of under-5 deaths,65 a systematic review dedicated to 
appraising the evidence of the effects of proactive case 
detection of neonatal conditions by CHWs in LMICs is 
merited.
COnClusIOns
Proactive case detection by CHWs may reduce child 
mortality and morbidity and increase access to care. The 
certainty of this evidence is low due to limitations in study 
designs, inconsistency in results, indirect measures of 
effect and important diversity between a small number of 
included studies. More research is needed on proactive 
case detection with rigorous study designs, standardised 
outcomes and measurement, and detail on intervention 
design and implementation.
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